Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: A prospective study

Genetics in Medicine

Volumn 16, Issue 5, 2014, Pages 374-378

  De Geyter, Christian ^a   M'Rabet, Nadira ^a   De Geyter, Julie ^a   Zürcher, Stephan ^a   Moffat, Rebecca ^a   Bösch, Nemya ^a   Zhang, Hong ^a   Heinimann, Karl ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

fragile X syndrome; infertility; ovarian reserve; population screening; primary ovarian insufficiency

Indexed keywords

CYTOSINE; FOLLITROPIN; GUANINE; MUELLERIAN INHIBITING FACTOR; 5' UNTRANSLATED REGION; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; INHIBIN; INHIBIN B;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FRAGILE X SYNDROME; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; MENSTRUAL CYCLE; MENTAL DEFICIENCY; OVARIAN RESERVE; POLYMERASE CHAIN REACTION; PREMATURE OVARIAN FAILURE; PREVALENCE; PROSPECTIVE STUDY; TRINUCLEOTIDE REPEAT; 5' UNTRANSLATED REGION; AMENORRHEA; BLOOD; CYTOLOGY; FERTILITY; GENETICS; LYMPHOCYTE;

5' UNTRANSLATED REGIONS; ADULT; AMENORRHEA; ANTI-MULLERIAN HORMONE; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; INFERTILITY, FEMALE; INHIBINS; LYMPHOCYTES; PRIMARY OVARIAN INSUFFICIENCY; PROSPECTIVE STUDIES; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84899959030     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.146     Document Type: Article

References (31)

1. Nolin SL, Brown WT, Glicksman A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003;72:454-464.
2. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-465.
3. Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet Med 2005;7:246-250.
4. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382.
5. Metcalfe S, Jacques A, Archibald A, et al. A model for offering carrier screening for fragile X syndrome to nonpregnant women: Results from a pilot study. Genet Med 2008;10:525-535.
6. Archibald AD, Hickerton CL, Jaques AM, Wake S, Cohen J, Metcalfe SA. 'It's about having the choice': Stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. Am J Med Genet A 2013;161A:48-58.
7. Musci TJ, Caughey AB. Cost-effectiveness analysis of prenatal populationbased fragile X carrier screening. Am J Obstet Gynecol 2005;192:1905-1912; discussion 1912.
8. Fanos JH, Spangner KA, Musci TJ. Attitudes toward prenatal screening and testing for Fragile X. Genet Med 2006;8:129-133.
9. Pastore LM, Morris WL, Karns LB. Emotional reaction to fragile X premutation carrier tests among infertile women. J Genet Couns 2008;17:84-91.
10. Hill MK, Archibald AD, Cohen J, Metcalfe SA. A systematic review of population screening for fragile X syndrome. Genet Med 2010;12:396-410.
11. Acharya K, Ross LF. Fragile X screening: Attitudes of genetic health professionals. Am J Med Genet A 2009;149A:626-632.
12. Bailey DB Jr, Bishop E, Raspa M, Skinner D. Caregiver opinions about fragile X population screening. Genet Med 2012;14:115-121.
13. Schwartz CE, Dean J, Howard-Peebles PN, et al. Obstetrical and gynecological complications in fragile X carriers: A multicenter study. Am J Med Genet 1994;51:400-402.
14. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 1999;83:322-325.
15. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004;89:4569-4574.
16. The American College of Obstetrics and Gynecologists Committee Opinion. Committe on Genetics. Carrier screening for Fragile X syndrome. Obstet Gynecol 2010;116:1008-1010.
17. The ESHRE Capri Workshop Group. Genetic aspects of female reproduction. Hum Reprod Update 2008;14:293-307.
18. M'Rabet N, Moffat R, Helbling S, Kaech A, Zhang H, De Geyter C. The CC-allele of the PvuII polymorphic variant in intron 1 of the a-estrogen receptor gene is significantly more prevalent among infertile women at risk of premature ovarian aging. Fertil Steril 2012;98:965-972.e1.
19. Nieschlag E. Care for the infertile male. Clin Endocrinol (Oxf) 1993;38:123-133.
20. Welt CK. Primary ovarian insufficiency: A more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008;68:499-509.
21. Hantash FM, Goos DG, Tsao D, et al. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening. Genet Med 2010;12:162-173.
22. Rodriguez-Revenga L, Madrigal I, Badenas C, XuncláM, Jiménez L, Mil?M. Premature ovarian failure and fragile X female premutation carriers: No evidence for a skewed X-chromosome inactivation pattern. Menopause 2009;16:944-949.
23. Spath MA, Nillesen WN, Smits AP, et al. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers. Am J Med Genet A 2010;152A:387-393.
24. Pesso R, Berkenstadt M, Cuckle H, et al. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn 2000;20:611-614.
25. Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G. Preconceptional and prenatal screening for fragile X syndrome: Experience with 40, 000 tests. Prenat Diagn 2007;27:991-994.
26. Bachelot A, Rouxel A, Massin N, et al.; POF-GIS Study Group. Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. Eur J Endocrinol 2009;161:179-187.
27. Bennett CE, Conway GS, Macpherson JN, Jacobs PA, Murray A. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod 2010;25:1335-1338.
28. Karimov CB, Moragianni VA, Cronister A, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod 2011;26:2077-2083.
29. Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, De Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril 2009;92:464-470.
30. Bodega B, Bione S, Dalpr?L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21:952-957.
31. Voorhuis M, Onland-Moret NC, Fauser BC, Ploos Van Amstel HK, Van Der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod 2013;28: 496-501.